Ertugliflozin: Phase III data

The double-blind, placebo-controlled Phase III VERTIS Factorial trial in 1,233 Type II diabetics inadequately controlled on metformin alone showed that once-daily 5 and 15 mg ertugliflozin plus 100 mg Januvia sitagliptin each met the

Read the full 341 word article

How to gain access

Continue reading with a
two-week free trial.